U.S. Securities and Exchange Commission
                             Washington, D.C. 20549

                             Form 10-QSB Amendment 1

[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
     ACT OF 1934

[_]  TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE EXCHANGE ACT

For the quarter ended: April 30, 2000

Commission file no.:  0-28155

                          NATURAL SOLUTIONS CORPORATION
                  --------------------------------------------
           (Name of small business issuer as specified in its charter)

                Nevada                                          88-0367024
-------------------------------                             -------------------
(State or other jurisdiction of                             (IRS Employer
incorporation or organization)                               Identification No.)

100 Volvo Parkway, Suite 200
Chesapeake, Virginia                                             23320
----------------------------------------                      --------------
(Address of principal executive offices)                         (Zip Code)

Issuer's telephone number :         (757) 548-4242

Securities registered under Section 12(b) of the Exchange Act:

                                                   Name of each exchange on
Title of each class                                     which registered

     None                                                   None
-------------------------                        -------------------------

Securities registered under Section 12(g) of the Exchange Act:

                          Common Stock, $.001 par value
                       -----------------------------------
                                (Title of class)

Copies of Communications Sent to:
                                     Mintmire & Associates
                                     265 Sunrise Avenue, Suite 204
                                     Palm Beach, FL 33480
                                     Tel: (561) 832-5696 Fax: (561) 659-5371


<PAGE>



Indicate by Check whether the issuer (1) filed all reports  required to be filed
by  Section  13 or 15(d) of the  Exchange  Act during the past 12 months (or for
such shorter period that the registrant was required to file such reports),  and
(2) has been subject to such filing requirements for the past 90 days.

                  Yes  X        No
                      ---         ---

State the number of shares  outstanding of each of the issuers classes of common
equity,  as of the latest  practicable  date:  As of April 30,  2000,  there are
20,026,540   shares  of  voting  common  stock  of  the  registrant  issued  and
outstanding.



<PAGE>




                          PART I FINANCIAL INFORMATION

Item 1.  Financial Statements


Consolidated Balance Sheets as of April 30, 2000 and 1999,
     and July 31, 1999.....................................................F-2

Consolidated Statements of Operations for the Three and Nine Months Ended
     April 30, 2000 and 1999...............................................F-3

Statements of Consolidated Cash Flows for the Nine Months Ended
     April 30, 2000 and 1999...............................................F-4

Notes to the Consolidated Financial Statements.............................F-5












<PAGE>



<TABLE>
<CAPTION>
                          NATURAL SOLUTIONS CORPORATION
                           Consolidated Balance Sheets

                                                (Unaudited)           (Unaudited)
                                               April 30, 2000        April 30, 1999        July 31, 1999
                                             -------------------   -------------------  --------------------
<S>                                          <C>                   <C>                  <C>
Current Assets:
    Cash and Cash Equivalents                          $126,252               $96,439                    $0
    Accounts Receivable - Trade                         110,020               445,382                86,339
    Other Receivables                                     9,968                   183                 5,375
    Inventories                                         671,209               630,494               626,872
    Prepaid Expenses                                     21,918               100,849                62,736
                                             -------------------   -------------------  --------------------
       Total Current Assets                             939,367             1,273,347               781,322

Property and Equipment, net                              93,561               126,953               112,453
Investment in Affiliate                                  18,750               233,713                18,750
Licensing Agreement, net                                364,259               445,300               419,620
Deferred Tax Asset                                            -               217,606                     -
Amounts Due From Related Parties                        212,908               157,467                54,741
Other                                                       905                   905                   905
                                             -------------------   -------------------  --------------------
                                                     $1,629,750            $2,455,291            $1,387,791
                                             ===================   ===================  ====================

Current Liabilites:
    Accounts Payable - Trade                            876,317               730,690             1,115,754
    Accured Expenses                                    282,875                18,422               235,597
    Note Payable                                         60,000                                           -
    Current Portion of Long Term Debt                    82,000                82,000               82,000
    Current Portion of Related Party Debt                     -                61,951              124,968
                                             -------------------   -------------------  --------------------
       Total Current Liabilities                      1,301,192               893,063            1,558,319

Long Term Debt to Related Parties                       257,000               313,762              132,032
Convertible Debenture                                   750,000                     -                    -

Stockholders' Equity:
    Preferred Stock, $0.01 par value,
      20,000,000 shares authorized, no shares
      have been issued or are outstanding                     -                     -                    -
    Common Stock, $0.01 par value,
      55,000,000 shares authorized,
      19,996,540 issued and outstanding                  20,297                15,997               15,997
    Additional Paid-in Capital                       12,789,154            11,775,167           11,770,954
    Other Comprehensive Income                          (96,250)                    -              (96,250)
    Accumulated Deficit                             (13,391,643)          (10,542,698)         (11,993,261)
                                             -------------------   -------------------  --------------------
       Total Stockholders' Equity                      (678,442)            1,248,466             (302,560)
                                             -------------------   -------------------  --------------------
                                                     $1,629,750            $2,455,291           $1,387,791
                                             ===================   ===================  ====================
</TABLE>


                 The accompanying notes are an integral part of
                          these financial statements.


                                       F-2

<PAGE>


<TABLE>
<CAPTION>
                          NATURAL SOLUTIONS CORPORATION
                      Consolidated Statements of Operations

                                      For the Three Months Ended              For the Nine Months Ended
                                                 April 30                              April 30
                                          2000              1999                2000              1999
                                     ---------------   ---------------     ---------------   ---------------
<S>                                  <C>               <C>                 <C>               <C>
Net Sales                                  $256,037          $201,302          $1,388,770        $1,744,101
Costs Applicable to Sales                   318,418           161,418           1,161,942         1,218,609
                                     ---------------   ---------------     ---------------   ---------------
    Gross Profit (Loss)                     (62,381)           39,884             226,828           525,492

Selling and Administrative Expenses         507,359           418,905           1,572,711         1,375,578
                                     ---------------   ---------------     ---------------   ---------------
    Losses from Operations                 (569,740)         (379,021)         (1,345,883)         (850,086)

Other Expense, net                          (20,515)            1,428             (52,499)            1,428
                                     ---------------   ---------------     ---------------   ---------------
Net Loss Before Taxes                      (590,255)         (377,593)         (1,398,382)         (848,658)

Income Taxes                                      -                 -                   -                 -
                                     ---------------   ---------------     ---------------   ---------------
Net Loss                                  ($590,255)        ($377,593)        ($1,398,382)        ($848,658)
                                     ===============   ===============     ===============   ===============

Weighted Average Common Shares
  Outstanding                            20,006,540        15,964,843          19,003,207        15,928,975
                                     ---------------   ---------------     ---------------   ---------------
Loss per Share                              ($0.03)           ($0.02)             ($0.07)           ($0.05)
                                     ===============   ===============     ===============   ===============
</TABLE>



                 The accompanying notes are an integral part of
                          these financial statements.




                                       F-3


<PAGE>



<TABLE>
<CAPTION>
                          NATURAL SOLUTIONS CORPORATION
                      Consolidated Statements of Cash Flows

                                                                        For the Nine Months Ended
                                                                                April 30
                                                                         2000             1999
                                                                    ---------------  ----------------
<S>                                                                 <C>              <C>
    Operating Activities:
    Net Loss                                                          ($1,398,382)        ($848,658)
    Non-Cash Expenses Included in Net Loss:
       Depreciation and Amortization                                       88,896            90,990
       Bad Debts                                                                -           (20,582)
       Product and Services Pruchased for Stock
          and Options                                                           -           381,169
    Adjustments to Reconcile Net Loss to Cash
      Provided (Consumed) by Operating Activities:
       (Increase) in Accounts Receivable                                  (23,681)         (106,304)
       (Increase) in Other Receivables                                     (4,593)                -
       (Increase) Decrease in Inventories                                 (44,337)           68,088
       (Increase) Decrease in Prepaid Expenses                             40,818            (3,284)
       Increase (Decrease) in Accounts Payable and
          Accrued Expenses                                               (206,802)          301,195
                                                                    ---------------  ----------------
    Cash Consumed by Operating Activities                              (1,548,081)          (137,386)

    Financing Activities:
       Proceeds from Issuance of Note Payable                              60,000                  -
       Proceeds from Issuance of Long Term Debt                           750,000            118,713
       Proceeds from Issuance of Common Stock                           1,022,500                  -
                                                                    ---------------  ----------------
    Cash Generated by Financing Activities                              1,832,500            118,713

    Investing Activities:
       Acquisition of Equipment                                                 -            (21,228)
       Advances and Charges to Related Parties                           (158,167)            (4,943)
       Payments Recevied on Advances to Related
         Parties                                                                -             60,995
       Investment in Affiliate                                                  -           (123,713)
                                                                    ---------------  ----------------
    Cash Provided (Used) in Investing Activities                         (158,167)           (88,889)

    Net Increase (Decrease) in Cash                                       126,252           (107,562)

    Cash and Cash Equivalents - Beginning                                       -            125,265
                                                                    ---------------  ----------------
    Cash and Cash Equivalents - Ending                                   $126,252            $17,703
                                                                    ===============  ================
</TABLE>


                 The accompanying notes are an integral part of
                          these financial statements.




                                       F-4



                          NATURAL SOLUTIONS CORPORATION
                      Notes to Interim Financial Statements
                                   Form 10-QSB
                                 April 30, 2000

Note 1.  The  interim  financial  statements include all adjustments,  which, in
         the opinion of management, are necessary in order to make the financial
         statements  not  misleading.   The  unaudited   consolidated  financial
         statements  and  notes  are  presented  as  permitted  by Form  10-QSB.
         Accordingly,  certain  information  and footnote  disclosures  normally
         included in financial  statements prepared in accordance with generally
         accepted  accounting  principles  have been omitted.  The  accompanying
         consolidated   financial   statements  and  notes  should  be  read  in
         conjunction  with the  audited  financial  statements  and notes of the
         Company for the year ended July 31, 1999. The results of operations for
         the  three-month  and  nine-month  periods ended April 30, 2000 are not
         necessarily indicative of those to be expected for the entire year.

Note 2.  The  financial  statements  as  of  April 30, 1999 and  for the periods
         ended April 30, 1999 have been restated to reflect year end adjustments
         to provide an  additional  allowance  for  doubtful  accounts  totaling
         $299,280 which have been allocated back to the applicable quarters. The
         result of this adjustment is to increase the loss per weighted  average
         common share  outstanding by $0.003 and $0.019 for the three months and
         nine months ended April 30, 1999, respectively.

Note 3.  On  August 11, 1999,  the  Company  borrowed  $750,000  from  a related
         party in the form of a convertible  debenture  bearing  interest at 10%
         per annum and  maturing on August 11,  2001.  Prior to  repayment,  the
         principal  and accrued and unpaid  interest may be  converted  into the
         Company's  common  stock at a price of $0.75 per share.  The  debenture
         includes two detachable warrants entitling the holder to purchase up to
         three million  shares of the Company s common stock at a price of $0.75
         per share.  The warrants expire as follows:  one million shares on July
         28,  2000 and two  million  shares  on August 9,  2004.  Certain  terms
         related to the  convertible  debenture  and  detachable  warrants  were
         amended in conjunction with the transaction described in Note 4 below.

Note 4.  Subsequent  to  April 30, 2000 and  in conjunction with a plan to raise
         up to $3 million in additional investment the Company borrowed $250,000
         from a  related  party in the form of a  convertible  debenture  baring
         interest at 10% per annum, secured by all the assets of the Company and
         maturing June 1, 2005.  Prior to  repayment,  the principal and accrued
         and unpaid interest may be converted into the Company's common stock at
         a price of $0.25 per share.  As a  condition  of the loan,  the Company
         amended  certain  provisions  of the  convertible  debenture  issued on
         August 11,  1999.  The amended  terms  include;  a) the revision of the
         conversion  rate to  common  stock  from  $0.75  per share to $0.25 per
         share, and b) secured the convertible  debenture with all the assets of
         the Company. In addition, the Company amended the exercise price of the
         two detachable  warrants,  issued in conjunction  with the  convertible
         debenture  issued on August  11,  1999 from  $0.75 to $0.25 per  common
         share.






                                       F-5


<PAGE>



Item 2. Management's Discussion and Analysis

Forward Looking Statements:

This Form 10-QSB  includes  "forward-looking  statements"  within the meaning of
Section 27A of the  Securities  Act of 1933, as amended,  and Section 21E of the
Securities  Exchange  Act of  1934,  as  amended.  All  statements,  other  than
statements of historical  facts,  included or  incorporated by reference in this
Form 10-QSB which address  activities,  events or developments which the Company
expects or anticipates will or may occur in the future, including such things as
future capital expenditures (including the amount and nature thereof), expansion
and growth of the Company's business and operations,  and other such matters are
forward-looking  statements.  These statements are based on certain  assumptions
and analyses made by the Company in light of its  experience  and its perception
of historical  trends,  current  conditions and expected future  developments as
well as other factors it believes are appropriate in the circumstances. However,
whether  actual  results  or  developments   will  conform  with  the  Company's
expectations and predictions is subject to a number of risks and  uncertainties,
general economic market and business conditions;  the business opportunities (or
lack  thereof)  that may be presented to and pursued by the Company;  changes in
laws or regulation;  and other factors,  most of which are beyond the control of
the Company.  Consequently,  all of the forward-looking  statements made in this
Form 10-QSB are  qualified by these  cautionary  statements  and there can be no
assurance  that the actual  results or  developments  anticipated by the Company
will be realized  or, even if  substantially  realized,  that they will have the
expected consequence to or effects on the Company or its business or operations.
The  Company   assumes  no  obligations  to  update  any  such   forward-looking
statements.

Overview:

The Company was formed to exploit in the United States certain  patents,  rights
to patents,  and other proprietary  products covered under a licensing agreement
to market  agricultural  co-products such as road de-icing and anti-icing,  dust
suppressant and road stabilization products. The products are marketed under the
protected  trade names of Ice Ban(R) and  Roadbind(TM).  These products are sold
through a network of direct  sales  representatives  and  licensed  distributors
throughout the United States.

Results of  Operations - The Three  Months Ended April 30, 2000  Compared to the
Three Months Ended April 30, 1999:

Net sales for the three months ended April 30, 2000 for continuing operations by
the Company  were  $256,037  compared to $201,302 for the same period last year;
resulting  in an increase of $54,735 or 27%.  The increase in sales is primarily
due to an  extended  winter snow  season,  which  increased  sales of Ice Ban(R)
products in February 2000. This extended winter snow season more than offset the
negative  effect on sales from the Company's  decision to restructure  its sales
organization  and  reduce  its  dependence  on  a  limited  number  of  specific
customers.  The Company  continues its efforts to establish its own sales force,
recruiting  new  distributors,  and  reducing  the  size  of  new  and  existing
distributor territories.  The gross profit (loss) for the current period totaled
($62,381)  or (24%) of sales,  compared  to $39,884,  or 20% for the  comparable
period  in the prior  year.  The  decline  in profit  margin is  largely  due to
increased  fixed storage and rail car leases,  which are spread over  relatively
few sales dollars and reduced unit selling  prices due to increased  competition
from former Ice Ban distributors.

Selling and  administrative  expenses totaled $484,859  compared to $418,905 for
the same period last year.  Increases in marketing  costs,  rent associated with
moving the Company's headquarters to Virginia,  additional legal fees associated
with the continuing  litigation,  and increased  insurance  costs were primarily
responsible for the increase in selling and administrative expenses of $65,954.

Losses from operations  totaled $547,240 compared to losses in the prior year of
$379,021,  an increase of $168,219.  Other expenses totaled $20,515 bringing the
net loss to $567,755 compared to a net loss of $377,593 for the same period last
year.

While the new management is in the process of a wide-ranging  assessment of each
cost item as well as the  marketing  and sales  efforts,  it is too early in the
process  to  predict  the steps  management  will  institute  as a  result.  But
management  has  increased and will  continue to seek to increase  sales,  lower
fixed  costs as a  percentage  of sales  and  either  settle or see  through  to
successful  conclusion  the  non-productive  litigation,  which  this  year  has
burdened the Company's bottom line. There can be no assurances that such efforts
will be successful.


<PAGE>


Liquidity and Capital Resources:

In  the  nine  months  ended  April  30,  2000,  operating  activities  consumed
$1,525,581  in cash as compared to $137,386 of cash  consumed in the  comparable
period in 1999.  This increase in cash consumed from fiscal year 1999 to 2000 is
largely due to increases in  receivables  and  inventories  associated  with the
timing of sales,  which occurred later in the current year winter selling season
compared to the same period last year. In addition, accounts payable and accrued
expenses  were  reduced by $206,802  compared to an increase of $301,195 for the
comparable prior period.  Finally, cash consumed by operations in the prior year
was  reduced by the  issuance  of stock and  options  to  purchase  product  and
services totaling $381,169. That practice was discontinued in the current year.

The Company  recorded an infusion of $1,750,000  from financing  activities from
the end of its fiscal year to April 30,  2000.  The infusion of funds took place
in two separate  transactions  with a related party.  Certain  elements of these
transactions were later amended as part of an additional infusion of $250,000 on
June 1, 2000.

The first transaction,  as amended, was a $750,000 convertible debenture bearing
interest at 10% per annum, secured by the assets of the Company, and maturing on
August 11,  2001.  Prior to  repayment,  the  principal  and  accrued and unpaid
interest may be converted  into the  Company's  common stock at a price of $0.25
per share.  The  debenture  included  two  detachable  warrants,  amended to one
warrant,  entitling  the holder to  purchase up to three  million  shares of the
Company's  common stock at $0.25 per share. The warrants expire on June 1, 2005.
As a part of the transaction a director and  significant  shareholder has agreed
to vote his shares consistent with the desires of this investor.

The  remaining  capital was raised  through the sale of four  million  shares of
common stock to a related  party for $1 million.  As a part of the  transaction,
the purchaser  acquired,  among other  rights,  the right to name up to three of
seven of the directors of the Company.

In  conjunction  with a plan to raise up to $3 million in additional  investment
the  Company  borrowed  $250,000  from a  related  party on June 1,  2000.  This
borrowing was in the form of a convertible  debenture baring interest at 10% per
annum,  secured by the assets of the Company and maturing June 1, 2005. Prior to
repayment,  the principal and accrued and unpaid  interest may be converted into
the Company's  common stock at a price of $0.25 per share. As a condition of the
loan, the Company amended certain provisions of the convertible debenture issued
on August 11, 1999.  The amended  terms  include;  a) the revision in the common
stock conversion rate from $0.75 per share to $0.25 per share and b) secured the
convertible  debenture with the assets of the Company. In addition,  the Company
replaced the two detachable warrants, issued in conjunction with the convertible
debenture  issued on August 11, 1999  amending the common stock  exercise  price
from $0.75 per common share to $0.25 per share.

The  Company is in  negotiations  with the  related  party that  loaned the most
recent  $250,000 to loan an  additional  $750,000.  In addition,  the Company is
seeking additional outside investment of $2 million to fund its long-term growth
plans.  The Company  believes that it is necessary to raise this additional debt
or equity capital in order to meet its  short-term  liquidity and solvency needs
over the next twelve months while  maintaining  operations  and  supporting  the
further expansion of the Company's sales force. Currently,  sales volumes of the
dust  suppressant  and road  stabilization  products do not  produce  sufficient
profits to support the expansion planned for the coming fiscal year.

Impact of the Year 2000 Issue:

The Year 2000 Issue is the result of potential problems with computer systems or
any equipment  with computer chips that use dates where the date has been stored
as just two digits  (e.g.  98 for 1998).  On January 1, 2000,  any clock or date
recording mechanism including date sensitive software which uses only two digits
to represent  the year,  may have  recognize  the date using 00 as the year 1900
rather  than  the  year  2000.   This  could  result  in  a  system  failure  or
miscalculations causing disruption of operations,  including among other things,
a temporary  inability  to process  transactions,  send  invoices,  or engage in
similar activities.

To date, the Company has not experienced any noticeable Year 2000  difficulties.
The  Company  intends to continue  to monitor  its Year 2000  compliance  and to
correct any noncompliance as it is discovered.


<PAGE>



                            PART II OTHER INFORMATION

Item 1.  Legal Proceedings.

1)   Jeffrey Johnson v. Natural Solutions,  Case No. CL-99-3185,  in the Circuit
     Court in and for Palm  Beach  County,  Florida.  This was a lawsuit  by Mr.
     Johnson  filed on  March  26,  1999,  seeking  to  enforce  his  employment
     agreement.  The employment agreement called for arbitration and the Company
     successfully  moved to have  the  case  arbitrated.  Johnson  has  filed an
     arbitration  proceeding  and the Company has  responded  with an answer and
     defenses. This matter is currently being arbitrated.

2)   Dianne  Johnson,  et al. v. Natural  Solutions,  et al., Case No.  99-8228,
     United States District Court,  Southern  District of Florida.  This lawsuit
     was filed on March 26,  1999 by the  Johnson  family,  seeking  damages for
     alleged breach of various security regulations and laws by NSC. The Company
     has successfully filed two Motions to Dismiss. The Johnson family has filed
     a second amended  complaint,  which NSC has also moved to dismiss.  NSC has
     filed a  counterclaim  to rescind the sale of founders  stock issued to the
     plaintiffs.  The stock  owned by the Johnson  family is founders  stock for
     which the Johnson family paid approximately $4,000 to the Company. Recently
     NSC has filed a  substantial  counterclaim,  alleging  breach of  fiduciary
     duty,  breach of securities  acts,  RICO,  fraud,  etc. against the Johnson
     family  arising  out of the  actions  of Warren D.  Johnson,  Jr.,  and the
     Johnson family in selling  restricted  founders  shares of stock in private
     sales before the  restrictions  were  lifted.  Initial  discovery  has been
     completed in this case. The parties to this and the following  listed legal
     action  have  been in  negotiations  to  reach a  settlement.  Although  no
     settlement has been reached, the parties continue to consider alternatives.

3)   Dianne Johnson and the Johnson Family vs. Natural Solutions Corporation, et
     al., Case No.  99-5305,  in the Circuit Court in and for Palm Beach County.
     This is a lawsuit by the Johnson  family seeking to rescind the sale of Ice
     Ban, Inc.  (New York) to the Company,  which sale occurred in the summer of
     1997,  based upon alleged  fraudulent  misrepresentations  surrounding  the
     ownership of the  so-called  Toth patent.  The Company has filed an answer,
     affirmative  defenses,  and a counterclaim  similar to the  counterclaim in
     item b) above. Discovery is proceeding,  but the case is not set for trial.
     The parties to this and the  previously  listed  legal  action have been in
     negotiations  to  reach a  settlement  between  the  parties.  Although  no
     settlement has been reached, the parties continue to consider alternatives.

4)   Natural  Solutions  Corporation, et  al. v. Sears  Oil, et  al.,  Case  No.
     99-3344.  In the  Circuit  Court in and for Palm  Beach  County.  This is a
     lawsuit  filed on April 6, 1999,  by the Company for tortious  interference
     with the  Company's  rights to the  so-called  Toth patent  acquired by Mr.
     George Janke from the Hungarian  inventors.  This action also claims breach
     of  fiduciary  duty,  breach of a  confidentiality  agreement  by Sears and
     others  acting in concert with Sears.  Service has been obtained on most of
     the  Defendants,  and  motions to  dismiss,  motions  for lack of  personal
     jurisdiction,  and  motions to  transfer  to New York are  scheduled.  Some
     limited discovery on jurisdiction has been undertaken in this case.

5)   Sears Oil  Company  v.  Natural  Solutions  Corporation,  et al.,  Case No.
     99-CV-704-DNH.  This is an action  filed on January 25,  1999,  in New York
     State  Court,  but  removed to the  United  States  District  Court for the
     Northern   District   of  New  York.   This   action   alleges   fraudulent
     misrepresentations  by NSC and others based upon the  ownership of the Toth
     patent  and  fraudulent   inducement  into  a  certain   contract  for  the
     distribution   of  product  in  New  England   based  upon  NSC's   alleged
     misrepresentations  regarding  ownership of the Toth patent.  The Plaintiff
     has amended  their  Complaint  to allege  patent  infringement  of the Toth
     patent.  In October 1999 Sears Oil and Sears  Petroleum  sought a temporary
     restraining order determining that SeaCo, LLC was the exclusive distributor
     for Ice Ban  products  in the New  England  States.  The Judge  denied  the
     Plaintiff's  request for a temporary  restraining  order and Sears withdrew
     its claim for  injunctive  relief.  NSC has answered the  complaint and has
     filed a counterclaim. The case is not set for trial.


<PAGE>



6)   Ice Ban  America,  Inc (the former name of NSC).  v.  Innovative  Municipal
     Products,  Inc., Case No.  99-00710,  State Court of New York. This lawsuit
     was filed on March 24, 1999,  by NSC to recover two hundred  fifty-thousand
     dollars  ($250,000)  owed to it by its  New  York  distributor,  Innovative
     Municipal   Products.   Innovative  has  filed  affirmative   defenses  and
     counterclaims  based  upon  alleged  misrepresentation  regarding  the Toth
     patent.   NSC  has   answered  and  filed   affirmative   defenses  to  the
     counterclaim.  Discovery  is ongoing in this case,  and it has not been set
     for trial.

7)   Natural Solutions  Corporation v. Terrabind  International,  Inc.,  Richard
     Jurgenson,  Joseph  Kroll,  Richard  Weinert:  This  case was  filed by the
     Company on May 15, 2000 in the Circuit Court of Palm Beach County, Florida,
     seeking  damages and  injunctive  relief  against  three  former  corporate
     officers, who formed Terrabind International,  Inc. The lawsuit claims that
     the three  officers  breached  their  fiduciary  duties to the  Company  by
     usurping certain  corporate  opportunities,  both in prospective  sales and
     potential patent applications,  in the Company's Roadbind America Division.
     The  pre-suit  investigation   uncovered  a  substantial  sale  to  Yakima,
     Washington that was directed from Roadbind America to Terrabind. The action
     seeks  damages  and  injunctive  relief  to  prevent  usurpation  of  other
     corporate opportunities and inventions developed by the Company.


Item 2. Changes in Securities and Use of Proceeds

On March 1, 2000 the Company  issued 30,000 shares of common stock in settlement
of a billing  dispute  with a  supplier.  The shares  were valued at $22,500 and
recorded as advertising expense.

Subsequent  to April 30, 2000 and in  conjunction  with a plan to raise up to $3
million in additional  investment the Company  borrowed  $250,000 from a related
party on June 1, 2000. This borrowing was in the form of a convertible debenture
baring  interest  at 10% per annum,  secured by the  assets of the  Company  and
maturing June 1, 2005. Prior to repayment,  the principal and accrued and unpaid
interest may be converted  into the  Company's  common stock at a price of $0.25
per share. As a condition of the loan, the Company amended certain provisions of
the convertible  debenture issued on August 11, 1999. The amended terms include;
a) the  revision  in the common  stock  conversion  rate from $0.75 per share to
$0.25 per share and b) secured the convertible  debenture with the assets of the
Company. In addition,  the Company replaced the two detachable warrants,  issued
in conjunction with the convertible debenture issued on August 11, 1999 amending
the common stock exercise price from $0.75 per common share to $0.25 per share.

Item 3.  Defaults in Senior Securities

         None

Item 4. Submission of Matters to a Vote of Security Holders.

         None


<PAGE>


Item 5.  Other Information

On April 27, 2000 Mr. George Janke, a co-founder, former chairman, director, and
CEO of the Company passed away. The following  paragraphs,  which  discussed his
passing, were included in a press release and subsequently filed Form 8-K.

Chesapeake,  Virginia  5/1/00;  Natural  Solutions  Corporation (OTC PS: ICEBE),
Natural Solutions Corporation's Chairman of the Board, Dr. M.G. (Pat) Robertson,
reported that Mr. George Janke,  co-founder  and former  Chairman and CEO of the
Company passed away last week.

Dr.  Robertson  stated,  "I am deeply  saddened to report that Mr.  George Janke
passed away last week.  George was the co-inventor of Ice Ban and Roadbind,  and
co-founder of Natural  Solutions  Corporation.  His contributions to the Company
cannot be measured and his insights will be sorely missed." Dr. Robertson added,
"We are  fortunate  that nearly a year ago,  George had the  foresight  to begin
transferring  leadership  of the  Company to others.  Prior to this past  winter
season,  we began  establishing  a new  management  team and  that  process  was
completed in March.  Although we will miss  George's  insights  and  experience,
Natural  Solutions'  management  is  continuing  to press  toward the  long-term
success of the Company."


Item 6.  Exhibits and Reports on Form 8-K

(a) The exhibits required to be filed herewith by Item 601 of Regulation S-B, as
described  in the  following  index of  exhibits,  are  incorporated  herein  by
reference, as follows:

Exhibit No.    Description
-----------  ------------------------------------------------------------
4.2          First Amendment to the Convertible Debenture Due August 2001

4.3          Convertible Debenture dated June 1, 2000

4.4          Stock Purchase Warrant W-3A

10.25        Security Agreement

27   *       Financial Data Schedule

--------------------------------------

*    Filed herewith

     (b)  No Reports on Form 8-K were filed  during the quarter  ended April 30,
          2000


<PAGE>


                                   SIGNATURES
                              --------------------

In accordance with the requirements of the Securities  Exchange Act of 1934, the
registrant  caused  this  Report to be signed on its behalf by the  undersigned,
thereunto duly authorized.

                          Natural Solutions Corporation (Registrant)

Date: October 2, 2000     By: /s/ Jimmy W. Foshee
                              -----------------------
                             Jimmy W. Foshee, President

                          By: /s/ Michael D. Klansek
                              -----------------------
                              Michael D. Klansek, Treasurer
                              and Chief Financial Office